Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis

Myelokathexis is a very rare form of chronic hereditary neutropenia resulting from impaired neutrophil releasing mechanism in the bone marrow. The recombinant human granulocyte-macrophage (molgramostim) and granulocyte (filgrastim, lenograstim) colony stimulating factors release the mature granulocy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pflügers Archiv 2000, Vol.440 (5 Suppl), p.R81-R082
Hauptverfasser:	Cernelc, P, Andoljsek, D, Mlakar, U, Pretnar, J, Modic, M, Zupan, I P, Zver, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - therapeutic use Adult Chronic Disease Female Filgrastim Granulocyte Colony-Stimulating Factor - therapeutic use Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use Humans Leukocyte Count Neutropenia - drug therapy Neutropenia - genetics Neutropenia - pathology Neutrophils - pathology Recombinant Proteins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!